Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("HIV vaccine trial")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 27

  • Page / 2
Export

Selection :

  • and

Negative social impacts among volunteers in an HIV vaccine efficacy trialFUCHS, Jonathan; DURHAM, Marcus; MCLELLAN-LEMAL, Eleanor et al.Journal of acquired immune deficiency syndromes (1999). 2007, Vol 46, Num 3, pp 362-368, issn 1525-4135, 7 p.Article

HIV vaccine trial participation among ethnic minority communities : Barriers, motivators, and implications for recruitmentNEWMAN, Peter A; NAIHUA DUAN; ROBERTS, Kathleen J et al.Journal of acquired immune deficiency syndromes (1999). 2006, Vol 41, Num 2, pp 210-217, issn 1525-4135, 8 p.Article

Willingness to participate in preventive HIV vaccine trials in a community-based cohort in south western UgandaRUZAGIRA, Eugene; WANDIEMBE, Symon; BUFUMBO, Leonard et al.TM & IH. Tropical medicine & international health. 2009, Vol 14, Num 2, pp 196-203, issn 1360-2276, 8 p.Article

Demographic and behavioral contextual risk groups among men who have sex with men participating in a phase 3 HIV vaccine efficacy trial : Implications for HIV prevention and behavioral/biomedical intervention trialsBARTHOLOW, Bradford N; GOLI, Vamshidar; ACKERS, Marta et al.Journal of acquired immune deficiency syndromes (1999). 2006, Vol 43, Num 5, pp 594-602, issn 1525-4135, 9 p.Article

Willingness to participate in HIV vaccine trials among men who have sex with men in Chennai and Mumbai, IndiaNEWMAN, Peter A; CHAKRAPANI, Venkatesan; WEAVER, James et al.Vaccine. 2014, Vol 32, Num 44, pp 5854-5861, issn 0264-410X, 8 p.Article

Use of predictive markers of HIV disease progression in vaccine trialsGURUNATHAN, S; EL HABIB, R; BAGLYOS, L et al.Vaccine. 2009, Vol 27, Num 14, pp 1997-2015, issn 0264-410X, 19 p.Article

Community perspectives on the ethical issues surrounding adolescent HIV vaccine trials in South AfricaJASPAN, Heather B; SOKA, Nosiphiwo F; STRODE, Ann E et al.Vaccine. 2008, Vol 26, Num 45, pp 5679-5683, issn 0264-410X, 5 p.Article

Partner-specific sexual behavioral differences between phase 3 HIV vaccine efficacy trial participants and controls : Project VISIONWHITTINGTON, William L. H; MORRIS, Martina; BUCHBINDER, Susan P et al.Journal of acquired immune deficiency syndromes (1999). 2006, Vol 43, Num 2, pp 234-238, issn 1525-4135, 5 p.Article

Feasibility of Identifying a Cohort of US Women at High Risk for HIV Infection for HIV Vaccine Efficacy Trials: Longitudinal Results of HVTN 906KOBLIN, Beryl A; METCH, Barbara; FRANK, Ian et al.Journal of acquired immune deficiency syndromes (1999). 2013, Vol 63, Num 2, pp 239-244, issn 1525-4135, 6 p.Article

HIV-vaccine Research and Development in Thailand: Evolution and challengesPITISUTTITHUM, Punnee; CHOOPANYA, Kachit; RERK-NGNAM, Supachai et al.Vaccine. Supplement. 2010, Vol 28, Num 2, issn 1359-5938, B45-B49Article

Behavioral and social issues among volunteers in a preventive HIV vaccine trial in thailandJENKINS, Richard A; THAPINTA, Darawan; SURIYANON, Vinai et al.Journal of acquired immune deficiency syndromes (1999). 2005, Vol 40, Num 5, pp 592-599, issn 1525-4135, 8 p.Article

Does participation in an HIV vaccine efficacy trial affect risk behaviour in South Africa?GRAY, G. E; METCH, B; CHURCHYARD, G et al.Vaccine. 2013, Vol 31, Num 16, pp 2089-2096, issn 0264-410X, 8 p.Article

Beyond the checklist : Assessing understanding for HIV vaccine trial participation in South AfricaLINDEGGER, Graham; MILFORD, Cecilia; SLACK, Catherine et al.Journal of acquired immune deficiency syndromes (1999). 2006, Vol 43, Num 5, pp 560-566, issn 1525-4135, 7 p.Article

Determinants of enrollment in a preventive HIV vaccine trial: Hypothetical versus actual willingness and barriers to participationBUCHBINDER, Susan P; METCH, Barbara; HOLTE, Sarah E et al.Journal of acquired immune deficiency syndromes (1999). 2004, Vol 36, Num 1, pp 604-612, issn 1525-4135, 9 p.Article

Factors associated with incarceration and incident human immunodeficiency virus (HIV) infection among injection drug users participating in an HIV vaccine trial in Bangkok,Thailand, 1999-2003SUNTHARASAMAI, Pravan; MARTIN, Michael; CHOOPANYA, Kachit et al.Addiction (Abingdon. Print). 2009, Vol 104, Num 2, pp 235-242, issn 0965-2140, 8 p.Article

Inhibitors and facilitators of willingness to participate (WTP) in an HIV vaccine trial: construction and initial validation of the Inhibitors and Facilitators of Willingness to Participate Scale (WPS) among women at risk for HIV infectionFINCHAM, Dylan; KAGEE, Ashraf; SWARTZ, Leslie et al.AIDS Care (Print). 2010, Vol 22, Num 4, pp 452-461, issn 0954-0121, 10 p.Article

Starting from scratch : Program development and lessons learned from HIV vaccine trial counseling in ThailandTHAPINTA, Darawan; JENKINS, Richard A.Contemporary clinical trials. 2007, Vol 28, Num 4, pp 409-422, issn 1551-7144, 14 p.Article

Willingness to participate in HIV vaccine trials among HIV-negative gay men in Sydney, AustraliaVAN DE VEN, Paul; LIMIN MAO; CRAWFORD, Lune et al.International journal of STD & AIDS. 2005, Vol 16, Num 4, pp 314-317, issn 0956-4624, 4 p.Article

Why blacks do not take part in HIV vaccine trialsMOUTSIAKIS, Demetrius L; CHIN, Nancy P.Journal of the National Medical Association. 2007, Vol 99, Num 3, pp 254-257, issn 0027-9684, 4 p.Article

Evaluation of an Intervention Among Adolescents to Reduce Preventive Misconception in HIV Vaccine Clinical TrialsLALLY, Michelle; GOLDSWORTHY, Richard; SARR, Moussa et al.Journal of adolescent health. 2014, Vol 55, Num 2, pp 254-259, issn 1054-139X, 6 p.Article

The Potential Role of Biomarkers in HIV Preventive Vaccine TrialsMACLACHLAN, Ellen; MAYER, Kenneth H; BARNABAS, Ruanne et al.Journal of acquired immune deficiency syndromes (1999). 2009, Vol 51, Num 5, pp 536-545, issn 1525-4135, 10 p.Article

A qualitative assessment of perspectives on the inclusion of adolescents in HIV vaccine trials in South AfricaJASPAN, H. B; SOKA, N. F; MATHEWS, C et al.International journal of STD & AIDS. 2010, Vol 21, Num 3, pp 172-176, issn 0956-4624, 5 p.Article

Sexual risk behaviour of the first cohort undergoing screening for enrolment into Phase 1/11 HIV vaccine trials in South AfricaANDERSSON, K. M; VAN NIEKERK, R. M; NICCOLAI, L. M et al.International journal of STD & AIDS. 2009, Vol 20, Num 2, pp 95-101, issn 0956-4624, 7 p.Article

Theoretical model of critical issues in informed consent in HIV vaccine trialsLEWIS, Cindi A; DEWHURST, Stephen; MCMAHON, James M et al.AIDS Care (Print). 2014, Vol 26, Num 11-12, pp 1452-1460, issn 0954-0121, 9 p.Article

Does message framing predict willingness to participate in a hypothetical HIV vaccine trial: An application of Prospect TheoryEVANGELI, Michael; KAFAAR, Zuhayr; KAGEE, Ashraf et al.AIDS Care (Print). 2013, Vol 25, Num 7-8, pp 910-914, issn 0954-0121, 5 p.Article

  • Page / 2